LDT (Tyzeka 600 mg)
Generic Name: telbivudine
Pill imprint LDT has been identified as Tyzeka 600 mg.
Tyzeka is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Tyzeka 600 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 600 mg
- Elliptical / Oval
- Prescription only
More about Tyzeka (telbivudine)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.